Cocrystals of Baicalein with Higher Solubility and Enhanced Bioavailability

被引:109
|
作者
Zhu, Bingqing [1 ,2 ]
Zhang, Qj [1 ]
Wang, Jian-Rong [1 ]
Mei, Xuefeng [1 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Pharmaceut Analyt & Solid State Chem Res Ctr, Shanghai 201203, Peoples R China
[2] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China
基金
中国国家自然科学基金;
关键词
IMPROVING SOLUBILITY; ORAL BIOAVAILABILITY; CANCER-CELLS; NICOTINAMIDE; DISSOLUTION; FORMULATION; POLYMORPHS; ADVANTAGE;
D O I
10.1021/acs.cgd.6b01863
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Baicalein (Bai) is one of the most, important bioactive flayonids isolated from the well-known traditional Chinese medicine called "Huang Qm". Though,it has broad therapeutic capability, the bioavailability is limited due to its poor solubility. In this study, we aimed to modulate its solubility-through cocrystallization. Cocrystals of Bai with isoniazide (Inia), isonicotinamide (Inam), caffeine (Caf), and theophylline (Tph) were obtained. And different cocrystallilation methods lead to different cocrystal phases for Inam and Tph. These cocrystals were characterized using powder X-ray diffraction, thermogravimetric analysis, differential scanning calorinietry, dynamic vapor :sorption, and Fourier transform infrared spectroscopy. Among all the cocrystals studied, BaiCaf is found to be superior in powder dissolution and pharmacokinetic behavior. Area under the curve values of BaiCaf is improved by a factor of 4:1, and the,bioavailability of baicalein is thus expected to be accordingly increased. Given that Caf is a central nervous system stimulant available in many prescription and nonprescription medications, BaiCaf can be a promising, alternative solid form: of Bai to be developed.
引用
收藏
页码:1893 / 1901
页数:9
相关论文
共 50 条
  • [21] Solubility Advantage of Pharmaceutical Cocrystals
    Good, David J.
    Rodriguez-Hornedo, Nair
    CRYSTAL GROWTH & DESIGN, 2009, 9 (05) : 2252 - 2264
  • [22] Enhanced Solubility and Dissolution of Drug-drug Cocrystals of Lopinavir-Ritonavir
    Chaudhari, Khushbu R.
    Savjani, Jignasa K.
    Savjani, Ketan T.
    Dahiya, Sandeep
    Bhangale, Jitendra O.
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2023, 57 (02) : S292 - S300
  • [23] On the solubility of saccharinate salts and cocrystals
    Cooke, Claire L.
    Davey, Roger J.
    CRYSTAL GROWTH & DESIGN, 2008, 8 (10) : 3483 - 3485
  • [24] Tracing the Architecture of Caffeic Acid Phenethyl Ester Cocrystals: Studies on Crystal Structure, Solubility, and Bioavailability Implications
    Ketkar, Sameer
    Pagire, Sudhir K.
    Goud, N. Rajesh
    Mahadik, Kakasaheb
    Nangia, Ashwini
    Paradkar, Anant
    CRYSTAL GROWTH & DESIGN, 2016, 16 (10) : 5710 - 5716
  • [25] Bioavailability of indomethacin-saccharin cocrystals
    Jung, Min-Sook
    Kim, Jeong-Soo
    Kim, Min-Soo
    Alhalaweh, Amjad
    Cho, Wonkyung
    Hwang, Sung-Joo
    Velaga, Sitaram P.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (11) : 1560 - 1568
  • [26] Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex
    Chen, Xiaoyu
    Sun, Xun
    Ren, Ke
    Zhang, Xiaoning
    Zhang, Zhirong
    Gong, Tao
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2010, 60 (09): : 571 - 574
  • [27] Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability
    Fangfang Zhang
    Jingwei Mao
    Guangyan Tian
    Hulin Jiang
    Qingri Jin
    AAPS PharmSciTech, 23
  • [28] Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability
    Zhang, Fangfang
    Mao, Jingwei
    Tian, Guangyan
    Jiang, Hulin
    Jin, Qingri
    AAPS PHARMSCITECH, 2022, 23 (01)
  • [29] Crystal Engineering for Enhanced Solubility and Bioavailability of Poorly Soluble Drugs
    Varshosaz, Jaleh
    Ghassami, Erfaneh
    Ahmadipour, Saeedeh
    CURRENT PHARMACEUTICAL DESIGN, 2018, 24 (21) : 2473 - 2496
  • [30] Glibenclamide-malonic acid cocrystal with an enhanced solubility and bioavailability
    Srivastava, Dipti
    Fatima, Zeeshan
    Kaur, Chanchal Deep
    Mishra, Anjali
    Nashik, Sanap Sachin
    Rizvi, Dilshad A.
    Prasad, Rammani
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2022, 48 (08) : 417 - 424